Log In
Monday 24th October 2016

Warning over epilepsy drug risk

6th August 2008

The UK drugs regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), has released new data that shows an increased risk of suicidal thoughts and behaviour with antiepileptic drugs.

The warning comes after a Europe-wide review of antiepileptic treatments found that about two in every 1,000 patients experienced suicidal thoughts or behaviour. In a recent Drug Safety Update, the MHRA is advising patients and carers to seek medical advice if they experienced any mood changes, distressing thoughts or any feelings about suicide.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016